48 results
8-K
ANNX
Annexon Inc
8 Jan 24
Regulation FD Disclosure
4:09pm
on Form 8-K and incorporated herein by reference.
As announced, management of Annexon will present at the 42nd Annual J.P. Morgan Healthcare Conference
8-K
EX-99.1
ANNX
Annexon Inc
8 Jan 24
Regulation FD Disclosure
4:09pm
for long-term treatment of chronic autoimmune conditions.
42nd Annual J.P. Morgan Healthcare Conference
Mr. Love will present an overview of Annexon … and outline the company’s pipeline updates at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2023, at 2:15 p.m. PT in San
8-K
EX-99.1
gt7kver
11 Oct 23
Annexon Announces Clinical and Regulatory Progress for ANX005 Pivotal
4:44pm
8-K
EX-99.2
wh2 fn60ku0czzfv
31 Jul 23
Annexon Biosciences Strengthens Leadership Team with Appointment of Jamie Dananberg, M.D., as Chief Medical Officer
4:30pm
424B3
o3tt6he8tgnpo
16 Nov 22
Prospectus supplement
4:26pm
S-3
4h6 9zkh4
4 Nov 22
Shelf registration
4:47pm
8-K
jt86n4k9u j5up2l
8 Jul 22
Annexon Announces $130 Million Private Placement Financing
5:19pm
8-K
EX-99.1
iv6hc
8 Jul 22
Annexon Announces $130 Million Private Placement Financing
5:19pm